Mad Money 27 September 2005

The Mortgage-Pro · Site Admin Joined: 19 Jan 2005 Posts: 2248

Jim Cramer’s Mad Money Recap 9/27/2705

Jim Cramer suggested a biotech play on Genzyme Corporation (NASDAQ NM: GENZ).

Genzyme announced today the commercial availability of a new laboratory test to help identify patients likely to respond to therapies targeted for the treatment of non-small cell lung cancer (NSCLC). Genzyme's EGFR Mutation Assay will help to detect the presence of epidermal growth factor receptor mutations in patients with NSCLC

GENZ was trading at $70.39as of the market close of 9/27/2705

Cramer also put forth a thesis on the food industry. He said since the whole group was up, when the market was done we may have a dismal future ahead. Investors usually buy this group when the economy is running out steam. The Fed’s relentless rate hikes may be starting to scare the major players on the street.

Jim Cramer likes:
General Mills, Inc. (NYSE:GIS) Prev. Close: 45.88
Unilever Plc (NYSE:UL) Prev. Close: 42.61
Altria Group Inc (NYSE:MO) Prev. Close: 72.52

Cramer also reminded us we are in a huge natural gas bull market.

Get you some of these:
Southwestern Energy Company (NYSE:SWN) Prev. Close: 65.48 ** Cramer issued a Mon back here. This company has many new wells in the works.
For the best of breed Gas play check out Chesapeake Energy Corp (OTHER OTC: CHKDK) and